Correlation Between Inhibrx and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Inhibrx and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Reviva Pharmaceuticals.
Diversification Opportunities for Inhibrx and Reviva Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Reviva is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Inhibrx i.e., Inhibrx and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibrx and Reviva Pharmaceuticals
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 2.79 times less risky than Reviva Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 112.00 in Reviva Pharmaceuticals Holdings on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Reviva Pharmaceuticals Holdings or generate 10.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Inhibrx |
| Reviva Pharmaceuticals |
Inhibrx and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Reviva Pharmaceuticals
The main advantage of trading using opposite Inhibrx and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Reviva Pharmaceuticals vs. Tff Pharmaceuticals | Reviva Pharmaceuticals vs. Eliem Therapeutics | Reviva Pharmaceuticals vs. Inhibrx | Reviva Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |